Market closedNon-fractional
Accuray/ARAY
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Accuray
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
Ticker
ARAY
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Madison, United States
Employees
1,024
Website
www.accuray.com
Accuray Metrics
BasicAdvanced
$186M
Market cap
-
P/E ratio
-$0.22
EPS
1.49
Beta
-
Dividend rate
Price and volume
Market cap
$186M
Beta
1.49
Financial strength
Current ratio
1.582
Quick ratio
0.698
Long term debt to equity
473.365
Total debt to equity
503.858
Interest coverage (TTM)
-0.36%
Management effectiveness
Return on assets (TTM)
-0.90%
Return on equity (TTM)
-44.87%
Valuation
Price to revenue (TTM)
0.423
Price to book
4.53
Price to tangible book (TTM)
-11.16
Price to free cash flow (TTM)
-7.581
Growth
Revenue change (TTM)
-2.00%
Earnings per share change (TTM)
101.61%
3-year revenue growth (CAGR)
4.22%
3-year earnings per share growth (CAGR)
63.62%
What the Analysts think about Accuray
Analyst Ratings
Majority rating from 4 analysts.
Accuray Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$101M
-5.69%
Net income
-$6.3M
-34.38%
Profit margin
-6.23%
-30.39%
Accuray Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
-$0.03
-$0.03
-$0.10
-$0.06
-
Expected
$0.01
-$0.05
-$0.05
-$0.01
$0.03
Surprise
-400.00%
-40.00%
100.00%
380.00%
-
Accuray News
AllArticlesVideos
Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care
PRNewsWire·4 weeks ago
Accuray and TrueNorth Medical Physics Sign Agreement to Provide Radiation Oncology Support Intended to Advance Cancer Care for More Patients
PRNewsWire·1 month ago
Accuray Announces Approval of the Accuray Precision® Treatment Planning System by China's National Medical Products Administration
PRNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Accuray stock?
Accuray (ARAY) has a market cap of $186M as of July 27, 2024.
What is the P/E ratio for Accuray stock?
The price to earnings (P/E) ratio for Accuray (ARAY) stock is 0 as of July 27, 2024.
Does Accuray stock pay dividends?
No, Accuray (ARAY) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Accuray dividend payment date?
Accuray (ARAY) stock does not pay dividends to its shareholders.
What is the beta indicator for Accuray?
Accuray (ARAY) has a beta rating of 1.49. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Accuray stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.